Suppr
超能文献

Combining EZH2 inhibition with senescence induction helps immune cells fight pancreatic cancer.

作者信息

Bordon Yvonne

机构信息

Nature Reviews Immunology, .

出版信息

Nat Rev Immunol. 2023 Jul;23(7):411. doi: 10.1038/s41577-023-00898-2.

DOI:10.1038/s41577-023-00898-2

PMID:37277561

Abstract

摘要

相似文献

Combining EZH2 inhibition with senescence induction helps immune cells fight pancreatic cancer.

Nat Rev Immunol. 2023 Jul;23(7):411. doi: 10.1038/s41577-023-00898-2.

Inhibiting enhancer of zeste homolog 2 promotes cellular senescence in gastric cancer cells SGC-7901 by activation of p21 and p16.

DNA Cell Biol. 2014 Jun;33(6):337-44. doi: 10.1089/dna.2014.2340. Epub 2014 Mar 3.

Inhibition enhancer of zeste homologue 2 promotes senescence and apoptosis induced by doxorubicin in p53 mutant gastric cancer cells.

Cell Prolif. 2014 Jun;47(3):211-8. doi: 10.1111/cpr.12103. Epub 2014 Apr 16.

Enhancer of zeste homolog 2 depletion induces cellular senescence via histone demethylation along the INK4/ARF locus.

Int J Biochem Cell Biol. 2015 Aug;65:104-12. doi: 10.1016/j.biocel.2015.05.011. Epub 2015 May 22.

EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21/CDKN1A expression.

Mol Cancer Res. 2011 Apr;9(4):418-29. doi: 10.1158/1541-7786.MCR-10-0511. Epub 2011 Mar 7.

Inhibition of enhancer of zeste homolog 2 (EZH2) expression is associated with decreased tumor cell proliferation, migration, and invasion in endometrial cancer cell lines.

Int J Gynecol Cancer. 2013 Jul;23(6):997-1005. doi: 10.1097/IGC.0b013e318296a265.

EZH2 coupled with HOTAIR to silence MicroRNA-34a by the induction of heterochromatin formation in human pancreatic ductal adenocarcinoma.

Int J Cancer. 2017 Jan 1;140(1):120-129. doi: 10.1002/ijc.30414. Epub 2016 Sep 19.

Regulation of pancreatic tumor cell proliferation and chemoresistance by the histone methyltransferase enhancer of zeste homologue 2.

Clin Cancer Res. 2008 Nov 1;14(21):6790-6. doi: 10.1158/1078-0432.CCR-08-1013.

Epigenetic Co-Deregulation of EZH2/TET1 is a Senescence-Countering, Actionable Vulnerability in Triple-Negative Breast Cancer.

Theranostics. 2019 Jan 24;9(3):761-777. doi: 10.7150/thno.29520. eCollection 2019.

EZH2 promotes cell migration and invasion but not alters cell proliferation by suppressing E-cadherin, partly through association with MALAT-1 in pancreatic cancer.

Oncotarget. 2016 Mar 8;7(10):11194-207. doi: 10.18632/oncotarget.7156.

引用本文的文献

Polymer-assisted PD-L1 degradation and targeted photodynamic therapy synergize to suppress immunodeficient tumors.

Acta Pharm Sin B. 2025 Jul;15(7):3805-3818. doi: 10.1016/j.apsb.2025.05.022. Epub 2025 May 26.

PRRX2 Regulates GLI2 to Promote Proliferation, Invasion, and Metastasis by Inhibiting Senescence via Hedgehog Signaling.

Cancer Sci. 2025 Sep;116(9):2427-2443. doi: 10.1111/cas.70134. Epub 2025 Jul 6.

Identification of CCNB1 as a biomarker for cellular senescence in hepatocellular carcinoma: a bioinformatics and experimental validation study.

Discov Oncol. 2025 Mar 24;16(1):384. doi: 10.1007/s12672-025-02182-2.

A stumbling block in pancreatic cancer treatment: drug resistance signaling networks.

Front Cell Dev Biol. 2025 Jan 13;12:1462808. doi: 10.3389/fcell.2024.1462808. eCollection 2024.

KDM4C-mediated senescence defense is a targetable vulnerability in gastric cancer harboring TP53 mutations.

Clin Epigenetics. 2023 Oct 17;15(1):163. doi: 10.1186/s13148-023-01579-6.

本文引用的文献

EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillance.

Nat Cancer. 2023 Jun;4(6):872-892. doi: 10.1038/s43018-023-00553-8. Epub 2023 May 4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr超能文献

Combining EZH2 inhibition with senescence induction helps immune cells fight pancreatic cancer.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译